status: 200
content-location: http://rest.kegg.jp/get/path:map07045
server: Apache
date: Wed, 15 Oct 2014 14:59:28 GMT
content-type: text/plain

ENTRY       map07045          Drug      Pathway
NAME        Antineoplastics - protein kinases inhibitors
PATHWAY_MAP map07045  Antineoplastics - protein kinases inhibitors
COMPOUND    D01441  Imatinib mesilate (JAN)
            D01977  Gefitinib (JAN/USAN/INN)
            D02714  Everolimus (JAN/USAN/INN)
            D03218  Axitinib (JAN/USAN)
            D03252  Bosutinib (USAN)
            D03257  Trastuzumab (genetical recombination) (JAN)
            D03350  Canertinib dihydrochloride (USAN)
            D03455  Cetuximab (genetical recombination) (JAN)
            D03658  Dasatinib (INN)
            D04014  Enzastaurin hydrochloride (JAN/USAN)
            D04023  Erlotinib hydrochloride (JAN/USAN)
            D04024  Lapatinib tosilate hydrate (JAN)
            D04696  Lestaurtinib (USAN/INN)
            D05029  Midostaurin (USAN/INN)
            D05350  Panitumumab (genetical recombination) (JAN)
            D05380  Pazopanib hydrochloride (JAN/USAN)
            D05446  Pertuzumab (genetical recombination) (JAN)
            D05819  Semaxanib (USAN/INN)
            D06005  Tandutinib (USAN/INN)
            D06068  Temsirolimus (JAN/USAN/INN)
            D06272  Sorafenib tosilate (JAN)
            D06285  Vatalanib (USAN/INN)
            D06402  Sunitinib malate (JAN/USAN)
            D06407  Vandetanib (JAN/USAN/INN)
            D06413  Nilotinib hydrochloride hydrate (JAN)
            D06414  Dasatinib hydrate (JAN)
            D06678  Motesanib
            D07907  Erlotinib (INN)
            D08066  Imatinib (INN)
            D08108  Lapatinib (INN)
            D08524  Sorafenib (USAN/INN)
            D08552  Sunitinib (INN)
            D08947  Motesanib phosphate (JAN)
            D08953  Nilotinib (USAN/INN)
            D09724  Afatinib (USAN/INN)
            D09728  Bosutinib hydrate (JAN)
            D09731  Crizotinib (JAN/USAN/INN)
            D09733  Afatinib maleate (JAN)
            D09955  Quizartinib (USAN/INN)
            D09956  Quizartinib dihydrochloride (USAN)
            D09959  Ruxolitinib (USAN/INN)
            D09960  Ruxolitinib phosphate (JAN/USAN)
            D09980  Trastuzumab emtansine (genetical recombination) (JAN)
            D10202  Bafetinib (USAN)
REFERENCE   PMID:15710326
  AUTHORS   Weisberg E, Manley PW, Breitenstein W, Bruggen J, Cowan-Jacob SW, Ray A, Huntly B, Fabbro D, Fendrich G, Hall-Meyers E, Kung AL, Mestan J, Daley GQ, Callahan L, Catley L, Cavazza C, Azam M, Neuberg D, Wright RD, Gilliland DG, Griffin JD.
  TITLE     Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.
  JOURNAL   Cancer Cell 7:129-41 (2005)
REFERENCE   PMID:17327610
  AUTHORS   Chow LQ, Eckhardt SG.
  TITLE     Sunitinib: from rational design to clinical efficacy.
  JOURNAL   J Clin Oncol 25:884-96 (2007)
REFERENCE   PMID:17956080
  AUTHORS   Veach DR, Namavari M, Pillarsetty N, Santos EB, Beresten-Kochetkov T, Lambek C, Punzalan BJ, Antczak C, Smith-Jones PM, Djaballah H, Clarkson B, Larson SM.
  TITLE     Synthesis and Biological Evaluation of a Fluorine-18 Derivative of Dasatinib.
  JOURNAL   J Med Chem : (2007)
REFERENCE   PMID:15685537
  AUTHORS   Debiec-Rychter M, Cools J, Dumez H, Sciot R, Stul M, Mentens N, Vranckx H, Wasag B, Prenen H, Roesel J, Hagemeijer A, Van Oosterom A, Marynen P.
  TITLE     Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.
  JOURNAL   Gastroenterology 128:270-9 (2005)
REFERENCE   PMID:17419150
  AUTHORS   von Mehren M.
  TITLE     Beyond imatinib: second generation c-KIT inhibitors for the management of gastrointestinal stromal tumors.
  JOURNAL   Clin Colorectal Cancer 6 Suppl 1:S30-4 (2006)
REFERENCE   PMID:17699867
  AUTHORS   Guo T, Agaram NP, Wong GC, Hom G, D'Adamo D, Maki RG, Schwartz GK, Veach D, Clarkson BD, Singer S, DeMatteo RP, Besmer P, Antonescu CR
  TITLE     Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor.
  JOURNAL   Clin Cancer Res 13:4874-81 (2007)
///
